In This Section

The AACR encourages all early-career investigators and those who support them to join in an all-day movement, the National Day of Action. Contact your members of Congress and let them know we must prioritize the future of cancer research!

Letter to President Biden Prioritizing COVID-19 Vaccines

130 Organizations, Cancer Centers, and Other Institutions Send Letter to Biden Urging Priority Access to a COVID-19 Vaccine for Cancer Patients and Survivors

Read Letter
Project Livin’ Label

This educational initiative in collaboration with the FDA fosters broader understanding of the oncology product label and increases awareness of recent oncology approvals.

Learn More
COVID-19 Policy Information

The AACR is committed to providing updated legislative and policy information on COVID-19 to our members and the public.

Learn More
Science Policy and Government Affairs Events

Learn More
Science Policy and Government Affairs at the AACR Annual Meeting

Learn More
AACR Letters, Policy Documents, and Position Statements

Learn More

From funding research grants to minimizing the barriers to clinical trials, the decisions made in Washington, D.C., directly influence the rate of progress in the war against cancer. Issues regarding health and science are becoming increasingly complex, and competition for limited resources is steadily increasing. These times require that cancer researchers become more actively involved in the policy-making process and take time to educate the public about the exciting progress occurring in the fight against cancer.

The AACR’s principal means for devising and implementing strategies to influence funding and important biomedical research-related public policy issues through The Science Policy and Government Affairs Committee and its subcommittees:

Science Policy and Government Affairs Committee. Provides guidance on public issues of concern to cancer researchers and focuses on mechanisms for speeding up cancer research.